AF
DFTX

Advisornet Financial’s Definium Therapeutics DFTX Stock Holding History

Advisornet Financial’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed -$11 – 2339
2023
Q4 		$11 Hold
3
– – ﹤0.01% 2426
2023
Q3 		$9 Hold
3
– – ﹤0.01% 2280
2023
Q2 		$11 Hold
3
– – ﹤0.01% 2343
2023
Q1 		$10 Hold
3
– – ﹤0.01% 2388
2022
Q4 		$7 Hold
3
– – ﹤0.01% 2378
2022
Q3 		$0 Hold
3
– – ﹤0.01% 1973
2022
Q2 		$0 Buy
+3
New +$38 ﹤0.01% 2048

Other funds holding DFTX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Advisornet Financial's DFTX Position: Q1 2024 in Review

Advisornet Financial sold out of Definium Therapeutics (DFTX) in Q1 2024, closing a stake of 3 shares — an estimated $11 sold.

Advisornet Financial first reported a position in DFTX in Q2 2022 and held it in 7 quarters. The position peaked at $11 in Q4 2023. 135 funds tracked by Wall St. Rank hold DFTX as of Q1 2024.

  • Advisornet Financial reported no remaining Definium Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Advisornet Financial sold 3 Definium Therapeutics shares in Q1 2024, an estimated $11.
  • Advisornet Financial first reported a position in Definium Therapeutics in Q2 2022 and held it in 7 quarters.
  • Advisornet Financial's Definium Therapeutics position peaked at $11 in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2024.

Based on Advisornet Financial's 13F filing for Q1 2024, filed 12 Apr 2024.